Nuezhenidic acid

CAS No. 183238-67-7

Nuezhenidic acid( —— )

Catalog No. M23832 CAS No. 183238-67-7

Nuezhenidic acid is a natural product, posseses inhibitory activities against influenza A virus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 538 In Stock
5MG 487 In Stock
10MG 655 In Stock
25MG 1017 In Stock
50MG 1293 In Stock
100MG 1553 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Nuezhenidic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    Nuezhenidic acid is a natural product, posseses inhibitory activities against influenza A virus.
  • Description
    Nuezhenidic acid is a natural product, posseses inhibitory activities against influenza A virus.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Microbiology/Virology
  • Target
    Influenza Virus
  • Recptor
    influenza A virus
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    183238-67-7
  • Formula Weight
    452.37
  • Molecular Formula
    C17H24O14
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COC(C(C(CC(O)=O)C1(CC(O)=O)O)=COC1OC(C(C1O)O)OC(CO)C1O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CEF6

    CEF6, a HLA-B7 restricted influenza virus nucleoprotein epitope, belongs to the CEF control peptides. The CEF control peptides are 8-12 amino acids in length, with sequences derived from the human cytomegalovirus, Epstein-Barr virus and influenza virus.

  • Baloxavir acid

    Baloxavir acid (S-033447, Baloxavir) is an anti-influenza compound that potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses.

  • Pimodivir

    Pimodivir (VX-787, JNJ872, JNJ 63623872) is a first-in-class, orally bioavailable inhibitor of influenza virus polymerase PB2 subunit with Kd of <3 nM, CPE EC50 of 2 nM.